Singapore markets closed

Straits Times Index
3,410.81
-29.07(-0.85%)
Nikkei
40,912.37
-1.28(-0.00%)
Hang Seng
17,799.61
-228.67(-1.27%)
FTSE 100
8,203.93
-37.33(-0.45%)
Bitcoin USD
57,858.67
+1,388.50(+2.46%)
CMC Crypto 200
1,202.59
-6.10(-0.50%)

Precigen, Inc. (PGEN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

1.4200

-0.0500

(-3.40%)

At close: 04:00PM EDT

1.5000

+0.08

(+5.63%)

After hours:

06:54PM EDT

Trade prices are not sourced from all markets

All

Simply Wall St.
Is Precigen (NASDAQ:PGEN) In A Good Position To Invest In Growth?
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Simply Wall St.
Precigen (NASDAQ:PGEN) shareholders are up 15% this past week, but still in the red over the last three years
Precigen, Inc. ( NASDAQ:PGEN ) shareholders should be happy to see the share price up 15% in the last week. But only...
PR Newswire
Precigen Announces Groundbreaking Pivotal Study Data for PRGN-2012 in Patients with Recurrent Respiratory Papillomatosis in Which More than Half of Patients Achieved Complete Response
Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today released positive Phase 1/2 pivotal study results for the investigational PRGN-2012 off-the-shelf (OTS) AdenoVerse® gene therapy in patients with recurrent respiratory papillomatosis (RRP). Results were presented in a late-breaking oral presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting by Scott